Introduction:
Hypercholesterolemia (HC) is a major driver of cumulative atherosclerotic cardiovascular disease (ASCVD) risk across the lifespan. While polygenic risk scores (PRS) for HC may complement monogenic familial hypercholesterolemia (FH) testing, their relationship to early-life LDL-C burden and clinical man...
Sarah C. Hanks, Laura Golfinopoulos, Priya N. Marathe et al.· Circulation· 0 citations
OBJECTIVES
The increasing integration of clinical genome sequencing (GS) into pediatric care has the potential to improve diagnostic understanding for children with neurodevelopmental disorders (NDDs), yet questions remain regarding how families interpret and experience genomic information. This study examined caregive...
Gabriella E. George, Rebecca Schecter, Joane Padilla et al.· Current Problems in Pediatri...· 0 citations
The Human Pangenome Reference Consortium’s (HPRC) Release 2 (HPRC2) is presented, an openly available, second phase pangenome that is an approximately fivefold expansion in genome number over HPRC Release 1 (HPRC1) and measurable improvement in genome completeness, contiguity, and accuracy.
Julian K. Lucas, Prajna Hebbar, Wen-Wei Liao et al.· bioRxiv· 6 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.